Treatment of Hamstring Muscle in Patients With Low-back Pain

Overview

This study evaluates the treatment of hamstrings in the management of patients with mechanical low back pain of non-specific origin. Half of the participants will received the application of a dry needle technique in the most hyperalgesic areas of the muscle, while the other half will received the same technique in areas not hyperalgesic.

Full Title of Study: “Effectiveness of Hamstring Muscle Dry Needling in Patients With Chronic Mechanical Low Back Pain of Non-specific Origin”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: December 30, 2020

Detailed Description

Shortening of the hamstrings could be related to low back pain.Therefore, the treatment of these muscles may improve pain. The dry needling technique seems to improve the extensibility of the muscles. This technique seems to be more effective when is applied in the most hyperalgesic areas related to the participant's pain. In order to demonstrate this hypothesis, the investigators will check if the dry needling technique produces the same effects when is applied in other areas of those same muscles

Interventions

  • Other: Dry needling in hamstring muscle trigger points
    • Participants with nonspecific mechanical low back pain will be assessed for the hamstring muscle. Subsequently, the most sensitive areas associated with the shortening of the muscle will be located and the technique will be applied to this area.
  • Other: Dry needling in hamstring muscle not trigger points
    • Participants with nonspecific mechanical low back pain will be assessed for the hamstring muscle. Subsequently, the most sensitive areas associated with the shortening of the muscle will be located and the technique will be applied out of this area.

Arms, Groups and Cohorts

  • Experimental: Grupo A. Dry needling in Trigger point
    • Participants will be treated in the most hyperalgesic foci within the hamstring musculature.
  • Placebo Comparator: Grupo B. Dry needling in non-hyperalgesic areas
    • Participants will be treated in non-hyperalgesic areas within the hamstring muscles.

Clinical Trial Outcome Measures

Primary Measures

  • Low back pain
    • Time Frame: Change from Baseline Pressure Pain Threshold at 3 months
    • The investigators use a Visual Analog Scale (VAS) to determine the intensity of the patient with blowback pain.The VAS is a 100-mm line, oriented horizontally, with one end representing “no pain” and the other end representing “worst pain.” Subjects will be asked to rate their current pain with a mark on the scale.

Secondary Measures

  • Disability with Oswestry Disability Index
    • Time Frame: Change from Baseline disability at 3 months
    • The Oswestry Disability Index (ODI) is a questionnaire used by clinicians and researchers to quantify disability for low back pain.The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel.Each topic category is followed by 6 statements describing different potential scenarios in the patient’s life relating to the topic. The patient then checks the statement which most closely resembles their situation. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible
  • The extensibility of the hamstring muscle
    • Time Frame: Change from Baseline disability at 3 months
    • The extensibility of the hamstring muscle will be measured by the popliteal or active knee extension (AKE) test, with the patient supine on the stretcher, with the contralateral limb in extension, will placed with the hip at 90 degrees of flexion. While maintaining this position, the clinician tries to extend the knee. Limitation of knee extension is measured with a goniometer in degrees.
  • Pressure Pain Threshold
    • Time Frame: Change from Baseline Pressure Pain Threshold at 3 months
    • The PPT serves to determine the sensitivity of hiperalgesic focus. The investigators will done it with one algometer. A lower threshold is a worse result. A higher threshold is a better result.

Participating in This Clinical Trial

Inclusion Criteria

  • Nonspecific chronic low back pain lasting ≥ 3 months. – Age between 18 and 65 years. – History of non-specific lumbar pain not irradiated to lower extremities of at least 1 year of evolution. – Those subjects who have not received a physiotherapy session in the last 6 months. Exclusion Criteria:

  • Specific low back pain (infection, tumor, inflammation, canal stenosis, spondylolisthesis, hernia or disc prolapse, structural deformity, rheumatic disease, radicular pain, cauda equina, previous history of spinal surgery). – Fibromyalgia. – Treatment with corticosteroids or oral medications in the last 6 months. – History of spinal surgery. – Contraindications typical of deep dry puncture (needle phobia, coagulation or psychological disorders, varicose regions, cysts, wounds, metal or latex allergy, lymphedema, hypothyroidism, diabetes). – Those subjects with a value of 0º in the Active Knee Extension (EAR) test. – Pregnancy

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Alcala
  • Provider of Information About this Clinical Study
    • Principal Investigator: Prof. Dr. Daniel Pecos Martín, Clinical professor – University of Alcala
  • Overall Official(s)
    • Tomas Gallego-Izquierdo, PhD, Study Chair, Alcala University
  • Overall Contact(s)
    • Daniel Pecos-Martin, PhD, +34 918855142, daniel.pecos@uah.es

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.